Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

The Senate Parliamentarian reversed course on a small provision in the One Big Beautiful Bill Act that could boost cures for ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug ...

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will be responsible for ...

Will the U.S. government adopt price controls on prescription drugs? If so, what would they look like? Seeking Alpha analysts ...